Literature DB >> 7734972

Mechanisms of nasal hyper-reactivity.

M Andersson1, L Greiff, C Svensson, C Persson.   

Abstract

Hyper-reactivity to non-specific challenges has been considered a hallmark of asthma and is defined as an abnormal responsiveness of the bronchial airways to a variety of provocative agents. The mechanisms underlying hyper-reactivity in the upper and lower airways are not known. By using the nose to study the inflammatory response possible abnormalities can be investigated carefully and pathophysiology of specific airway hyper-reactivities can be better understood. Other factors than merely constriction of the bronchial smooth muscles can cause narrowing of the free lumen to airflow. Functionally different and very distinct mucosal end-organ reactivities may also be increased. If these reactivities can be well assessed, specific airway hyper-reactivity can be defined. In the present report, specific mucosal end-organ hyper-reactivities in the allergic nasal mucosa are presented. Certain widespread hypotheses, such as the role of the eosinophil and the "increased absorption permeability theory", are disputed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7734972      PMCID: PMC7087639          DOI: 10.1007/bf02484430

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Allergen-induced hyperreactivity is not a feature of dermal immediate allergic reactions--in contrast to reactions of airways mucosa.

Authors:  M Andersson; U Pipkorn
Journal:  Clin Allergy       Date:  1988-03

2.  Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation.

Authors:  W J Metzger; D Zavala; H B Richerson; P Moseley; P Iwamota; M Monick; K Sjoerdsma; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1987-02

3.  Eosinophil chemotactic activity of topical PAF on the human nasal mucosa.

Authors:  H Klementsson; M Andersson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx.

Authors:  H Klementsson; M Andersson; U Pipkorn
Journal:  J Allergy Clin Immunol       Date:  1990-10       Impact factor: 10.793

5.  Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis.

Authors:  J T Connell
Journal:  J Allergy       Date:  1969-01

6.  Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man.

Authors:  E Henocq; B B Vargaftig
Journal:  Lancet       Date:  1986-06-14       Impact factor: 79.321

Review 7.  Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.

Authors:  F E Hargreave; G Ryan; N C Thomson; P M O'Byrne; K Latimer; E F Juniper; J Dolovich
Journal:  J Allergy Clin Immunol       Date:  1981-11       Impact factor: 10.793

8.  Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes.

Authors:  H Klementsson; P Venge; M Andersson; U Pipkorn
Journal:  Acta Otolaryngol       Date:  1991       Impact factor: 1.494

9.  Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA.

Authors:  L Greiff; P Wollmer; C Svensson; M Andersson; C G Persson
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

10.  Nasal methacholine challenge. A test for the measurement of nasal reactivity.

Authors:  P Borum
Journal:  J Allergy Clin Immunol       Date:  1979-04       Impact factor: 10.793

View more
  2 in total

1.  Nasal histamine responses in nonallergic rhinitis with eosinophilic syndrome.

Authors:  Giampietro Zambetti; Andrea Ciofalo; Raffaello Romeo; Pietro Soldo; Massimo Fusconi; Antonio Greco; Giuseppe Magliulo; Marco de Vincentiis
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 2.  Airway permeability.

Authors:  C G Persson; M Andersson; L Greiff; C Svensson; J S Erjefält; F Sundler; P Wollmer; U Alkner; I Erjefält; B Gustafsson
Journal:  Clin Exp Allergy       Date:  1995-09       Impact factor: 5.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.